Gut microbiota, obesity and diabetes E. Patterson; P. M. Ryan; J. F. Cryan; T. G. Dinan; R. P. Ross; G. F. Fitzgerald; C. Stanton Gut microbiota, obesity and diabetes Postgrad Med J Insulin resistance & diabetes Medications Metabolic Health
Targeting the microbiota to address diet-induced obesity: a time dependent challenge S. F. Clarke; E. F. Murphy; O. O'Sullivan; R. P. Ross; P. W. O'Toole; F. Shanahan; P. D. Cotter Targeting the microbiota to address diet-induced obesity: a time dependent challenge PLoS One Animal Studies Medications
Microbiota and body weight control: Weight watchers within? S. Boscaini; S. J. Leigh; A. Lavelle; R. García-Cabrerizo; T. Lipuma; G. Clarke; H. Schellekens; J. F. Cryan Microbiota and body weight control: Weight watchers within? Mol Metab Bariatric Surgery Dietary Studies Medications
A prospective randomized controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes A. Tuthill; A. Quinn; D. McColgan; M. McKenna; D. O'Shea; T. J. McKenna A prospective randomized controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes Diabetes, obesity & metabolism Dietary Studies Medications Physical Activity/Exercise T2DM
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation I. Lingvay; P. Sumithran; R. V. Cohen; C. W. le Roux Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation Lancet Medications T2DM
Low-Carbohydrate Diets in the Management of Obesity and Type 2 Diabetes: A Review from Clinicians Using the Approach in Practice T. Kelly; D. Unwin; F. Finucane Low-Carbohydrate Diets in the Management of Obesity and Type 2 Diabetes: A Review from Clinicians Using the Approach in Practice Int J Environ Res Public Health Cholesterol Medications T2DM Weight loss / Management
Impact of intentional weight loss on diabetic kidney disease J. A. Holland; W. P. Martin; N. G. Docherty; C. W. le Roux Impact of intentional weight loss on diabetic kidney disease Diabetes Obes Metab Bariatric Surgery Chronic Kidney Disease Medications T2DM
Improving understanding of type 2 diabetes remission: research recommendations from Diabetes UK’s 2019 remission workshop M. Hopkins; R. Andrews; V. Salem; R. Taylor; C. W. le Roux; E. Robertson; E. Burns Improving understanding of type 2 diabetes remission: research recommendations from Diabetes UK’s 2019 remission workshop Diabet Med Bariatric Surgery Dietary Studies Medications T2DM
Metabolic Inflammation in Obesity-At the Crossroads between Fatty Acid and Cholesterol Metabolism S. Curley; J. Gall; R. Byrne; L. Yvan-Charvet; F. C. McGillicuddy Metabolic Inflammation in Obesity-At the Crossroads between Fatty Acid and Cholesterol Metabolism Mol Nutr Food Res Cholesterol Medications
Conjugated Linoleic Acid and Alpha Linolenic Acid Improve Cholesterol Homeostasis in Obesity by Modulating Distinct Hepatic Protein Pathways M. E. O'Reilly; Y. M. Lenighan; E. Dillon; S. Kajani; S. Curley; R. Bruen; R. Byrne; A. M. Heslin; A. P. Moloney; H. M. Roche; F. C. McGillicuddy Conjugated Linoleic Acid and Alpha Linolenic Acid Improve Cholesterol Homeostasis in Obesity by Modulating Distinct Hepatic Protein Pathways Mol Nutr Food Res Cholesterol Medications